Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
Clinical trial NCT02422121 · COMPLETED
Trial details
- NCT number
- NCT02422121
- Sponsor
- Revalesio Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.